| Followers | 3804 |
| Posts | 244703 |
| Boards Moderated | 0 |
| Alias Born | 07/30/2007 |
Wednesday, June 01, 2022 10:38:12 PM
@bc9114 The $12.5m ( 5,193,187 shares) in shares distribution to G42 Healthcare were dilutive shares resulting in a increase in total outstanding shares from 90,036,637 to 95,229,824. The float will remain at 30,346,158 because G42 Healthcare will become an affiliate in the next 30 days.
“Lock-Up Period” means the period from the date of this Agreement until December 31, 2024 (or, if earlier, the date of receipt of FDA Approval). I love this Lock-Up Period : ) which is located on page 5.
These particular shares are classified as Unregistered Securities that orginated from the LPC Agreement which had $35.9 remaining available as of March 31st, 2022 & as a result of the G42 Healthcare Partnership the remaining availability under the LPC Agreement is now at $23.4m.
Common Stock Purchase Agreement: (Unregistered Securities)
sec.gov/Archives/edgar/data...
In the next 30 days Vtv's board will increase to 6 & will add
Dr. Fahed Al Marzooqi the COO of G42 Healthcare.
“Lock-Up Period” means the period from the date of this Agreement until December 31, 2024 (or, if earlier, the date of receipt of FDA Approval). I love this Lock-Up Period : ) which is located on page 5.
These particular shares are classified as Unregistered Securities that orginated from the LPC Agreement which had $35.9 remaining available as of March 31st, 2022 & as a result of the G42 Healthcare Partnership the remaining availability under the LPC Agreement is now at $23.4m.
Common Stock Purchase Agreement: (Unregistered Securities)
sec.gov/Archives/edgar/data...
In the next 30 days Vtv's board will increase to 6 & will add
Dr. Fahed Al Marzooqi the COO of G42 Healthcare.
Recent VTVT News
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 05/13/2026 09:22:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 09:20:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/13/2026 09:18:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:21:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:18:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 08:35:39 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/10/2026 08:32:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:51:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:11:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 09:18:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 10:10:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:32:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 09:26:47 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/03/2025 08:38:50 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/25/2025 09:06:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2025 05:03:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/02/2025 01:00:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2025 08:09:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2025 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2025 08:25:07 PM
